Brooke Kindall, CNM
Advanced Practice Midwife · Lees Summit, MONPI 1063043263
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,309 of the $4,233 with a category attached, or 78.2%. 26 manufacturers reported payments, led by Axonics, Inc. at 33.5% of the total. Reporting peaked in 2022 at $2,176 and has fallen 75.8% since, to $527 in 2025. Among advanced practice midwife clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 204 payments — averaging $20.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$1K
- AbbVie$876
- Astellas Pharma US Inc$524
- Sumitomo Pharma America, Inc.$461
- Mayne Pharma Commercial LLC$161
- Agile Therapeutics, Inc.$116
- plus $680 from 20 others
What the payments were for
- Travel & lodging$91022%
- Food & beverage$3,30978%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 16 | $1,416 |
| AbbVie(2 entities) | 65 | $876 |
| Astellas Pharma US Inc | 25 | $524 |
| Sumitomo Pharma America, Inc. | 44 | $461 |
| Mayne Pharma Commercial LLC | 12 | $161 |
| Agile Therapeutics, Inc. | 7 | $116 |
| Pfizer | 4 | $84 |
| Coloplast | 4 | $70 |
| Hologic Sales And Service, LLC | 3 | $58 |
| Urovant Sciences Inc | 3 | $58 |
| 180 Medical, Inc. | 2 | $56 |
| Medtronic | 1 | $42 |
| Therapeuticsmd, Inc. | 2 | $36 |
| Exeltis, USA Inc. | 2 | $35 |
| Scynexis, Inc. | 2 | $32 |
| Bayer | 2 | $31 |
| Organon | 1 | $23 |
| Mylan Pharmaceuticals Inc. | 1 | $23 |
| Acera Surgical, Inc. | 1 | $22 |
| Evofem Biosciences, Inc. | 1 | $19 |
| Johnson & Johnson | 1 | $17 |
| Millicent US Inc | 1 | $16 |
| Amgen | 1 | $15 |
| Aspira Women's Health Inc | 1 | $15 |
| Bausch Health US, LLC | 1 | $15 |
| Myovant Sciences Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,233 in reported general payments places this provider in the 95th percentile of 76 advanced practice midwife providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 138 | $84,444 |
| MyrbetriqMirabegron | 75 | $43,343 |
| Estradiol | 195 | $14,333 |
| ImvexxyEstradiol | 20 | $6,129 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 124 | $1,818 |
| Clindamycin Phosphate | 22 | $1,348 |
| Clobetasol Propionate | 32 | $952 |
| YuvafemEstradiol | 18 | $705 |
| Solifenacin Succinate | 15 | $314 |
| Levofloxacin | 21 | $243 |
| Fluconazole | 29 | $176 |
| Doxycycline Hyclate | 15 | $115 |
| Diazepam | 19 | $105 |
| Ciprofloxacin Hcl | 21 | $96 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 25 | $54 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $461 | $84,444138 claims |
| Astellas Pharma US IncMyrbetriq | $524 | $43,34375 claims |
| Therapeuticsmd, Inc.Imvexxy | $36 | $6,12920 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 76 advanced practice midwife providers in Missouri.
Other advanced practice midwife in Lees Summit
- Jessica CisnerosLees Summit$532
- Melissa JonasLees Summit$120
- Aja GreerLees Summit$110
- Krysta Ramirez HenryWarrensburg$20K
- Constance PfingstagSaint Louis$16K
- Jane VeselLake St Louis$3K
- Sarah GillKansas City$3K
- Shiela FrimmlFestus$2K
- Tamara YoungSaint Louis$2K
- Lori MaybrierColumbia$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.